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Purpose
Primary dysmenorrhea is highly prevalent among adoles-
cent women and a major cause of activity restriction. Stan-
dard pharmaceuticals for dysmenorrhea have side effects
that may limit their use. Acupoint injection of vitamin K
has been used to treat dysmenorrhea at the Obstetrics &
Gynecology Hospital in Shanghai, China since at least
1985. The purpose of this study was to examine feasibility
and acceptability of acupoint injection of vitamin K1 for
primary dysmenorrhea among US women and to assess
preliminary data on efficacy.
Methods
We conducted a crossover trial where study participants
were randomized to receive either 1) vitamin K1 injection
in the acupoint Spleen-6 at the start of their menstrual
cycle followed by a saline injection in a non-acupoint two
months later or 2) saline in a non-acupoint followed by
vitamin K1 in Spleen-6 two months later. Pain intensity
was measured before and after each treatment.
Results
A total of 18 women with primary dysmenorrhea (mean
age = 22 years) enrolled in the study. After participating
94% would still agree to go through with the injection
therapy and 77% would come every month if the treat-
ment were available. Based on a 0 to 10 numeric rating
scale at baseline and 60 minutes after injection, when
receiving vitamin K in Spleen-6, women had an average
2.5 point decrease in pain (4.1 to 1.6). When receiving
saline in a non-acupoint, average pain decreased by 1.8
points (4.5 to 2.6).
Conclusion
Results from this pilot study suggest high acceptability
of acupoint injection of vitamin K as a treatment for
primary dysmenorrhea among American women. While
decreases in pain were observed for both the treatment
and control, a trend towards larger pain reduction was
seen for vitamin K/Spleen-6 injection. This is consistent
with studies conducted in Shanghai, where this treat-
ment protocol was initially developed.
Author details
1Univ of California, San Francisco, Osher Center for Integrative Med, San
Francisco, USA.
2Institute of East West Medicine, New York City, USA.
Published: 12 June 2012
doi:10.1186/1472-6882-12-S1-P100
Cite this article as: Chao and Wade: P02.44. A pilot crossover trial of
acupoint injection for treating primary dysmenorrhea. BMC
Complementary and Alternative Medicine 2012 12(Suppl 1):P100.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1Univ of California, San Francisco, Osher Center for Integrative Med, San
Francisco, USA
Full list of author information is available at the end of the article
Chao and Wade BMC Complementary and Alternative
Medicine 2012, 12(Suppl 1):P100
http://www.biomedcentral.com/1472-6882/12/S1/P100
© 2012 Chao and Wade; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.